Search Results
Sep 09, 2026, 08:00 ET Ultima Genomics to Advance Pangenome-Aware Whole Genome Sequencing Analysis at Population Scale in Collaboration with NVIDIA, using Google's DeepVariant
precision medicine programs, and biobanks globally, pangenome-aware analysis has become an important tool to enable higher sensitivity and precision of NGS and to reduce genome reference bias by capturing global human genetic diversity. By combining Ultima's high-output, cost-efficient sequencing platform
More news about: Ultima Genomics
Sep 08, 2026, 10:15 ET Laboratory Mixers Market worth $2.74 billion by 2031 - Exclusive Report by MarketsandMarkets™
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) - Global
More news about: MarketsandMarkets
Sep 03, 2026, 10:00 ET Pillar Biosciences Appoints Todd Christian and Yann Echelard, Ph.D., to Its Board of Directors
Appointments follow the latest strategic financing to support joint NGS automation strategies and advance IVD development and commercializationNATICK, Mass., Sept. 3, 2026 /PRNewswire/ -- Pillar Biosciences, a
More news about: Pillar Biosciences, Inc.
Sep 03, 2026, 08:55 ET AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
described is the same one.Twist Bioscience Corporation (Nasdaq: TWST) operates further down the stack again, manufacturing synthetic DNA and NGS tools that the discovery industry consumes as raw input. The company
More news about: Equity Insider
Sep 02, 2026, 16:30 ET ePlus Achieves Exclusive Ambassador Partner Status with Everpure
tierHERNDON, Va., Sept. 2, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Sep 02, 2026, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for September 2026
Mega-practicesLABORATORY TECHNOLOGYSep 1 - Improve Regulatory Compliance for Pipetting and Liquid Handling WorkflowsSep 3 - Unlocking High-Quality NGS Data from Challenging Clinical SamplesSep 22 - Modernizing Centrifugation for Cell Separation, Washing and RecoveryPATIENT RECRUITMENT
More news about: Xtalks
Sep 01, 2026, 16:05 ET Palo Alto Networks Reports Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results
Net New NGS ARR in a single quarter," said Nikesh Arora, chairman and chief executive officer of Palo Alto Networks. "The latest advancements in AI are elevating cybersecurity to the top of the CIO priority list, and will serve as durable tailwinds as we progress towards our $20 billion FY30 NGS ARR target.""We
More news about: Palo Alto Networks, Inc.
Aug 27, 2026, 10:15 ET Pillar Biosciences and Hamilton Expand Automated NGS Library Preparation Method for oncoReveal® Nexus 21 Gene Panel on Hamilton Microlab STAR™ and STARlet™ Liquid Handling Systems
release of the latest automated NGS library preparation method under their NGS Application Development and Co-Marketing Agreement for the on Hamilton Microlab® STAR™and STARlet™ liquid handling systems. This latest milestone expands the growing portfolio of automated NGS workflows designed to help laboratories
More news about: Pillar Biosciences, Inc.
Aug 27, 2026, 10:04 ET Harbour BioMed Reports 2026 Interim Results: Three Integrated Growth Engines Accelerate Execution of Its Platform-Based Strategy
Hu-mAtrIx™ AI platform, strengthening capabilities including a fully human heavy-chain-only antibody model based on large-scale next-generation sequencing (NGS) HCAb sequence data, de novo design model, developability prediction, in silico screening and AI-guided engineering. The Company also continued
More news about: Harbour BioMed
Aug 26, 2026, 20:00 ET Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
rather than memorized them.The competition comprised three tasks. Challenge 1 focused on in-silico affinity maturation: from organizer-supplied NGS data covering only the first stage of the parental antibody's affinity maturation, participants had to design new antibodies outright — higher in affinity,
More news about: Aureka
Aug 26, 2026, 10:38 ET Strengthen Total AAV Potency Assurance with NGS Sequence Analysis, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how next-generation sequencing (NGS) can support total potency assurance for adeno-associated virus therapies. The featured speaker will discuss how NGS-based testing can assess sequence purity and quantify sequence variants or vector sub-populations as part of a total
More news about: Xtalks
Aug 25, 2026, 09:00 ET Lexogen Expands NGS Services with GCLP-Compliant Workflows
/PRNewswire/ -- Lexogen, a specialist in RNA sequencing technologies and next-generation sequencing services, announces the availability of designated NGS service workflows operated in compliance with the principles of the World Health Organization's Good Clinical Laboratory Practice guidance.
More news about: LEXOGEN
Aug 25, 2026, 09:00 ET Lexogen Expands NGS Services with GCLP-Compliant Workflows
/PRNewswire/ -- Lexogen, a specialist in RNA sequencing technologies and next-generation sequencing services, announces the availability of designated NGS service workflows operated in compliance with the principles of the World Health Organization's Good Clinical Laboratory Practice guidance.
More news about: LEXOGEN
Aug 24, 2026, 09:15 ET ePlus Acquires Assets of Daymark Solutions
PresenceHERNDON, Va., Aug. 24, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Aug 21, 2026, 10:15 ET Flow Cytometry Market worth $10.57 billion by 2034 - Exclusive Report by MarketsandMarkets™
Testing Market by Type (Endocrinology, Oncology, Neurology, Genetic Tests, Autoimmune, Infectious Diseases), Technology (ELISA, CLIA, Flow Cytometry, NGS, RT-PCR, Chromatography, Spectrometry), Specimen (Blood, Urine) - Global Forecast to 2029
More news about: MarketsandMarkets
Aug 19, 2026, 10:00 ET Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer
patients with lung cancer.The planned use of oncoReveal Essential+ within the LC-SCRUM-Asia project reflects the assay's ability to support targeted NGS analysis from blood-based specimens within a decentralized laboratory workflow.About LC-SCRUM-AsiaLC-SCRUM-Asia is
More news about: Pillar Biosciences, Inc.
Aug 17, 2026, 10:30 ET Cancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™
growing adoption of precision medicine are further accelerating market growth. Healthcare providers are increasingly utilizing next-generation sequencing (NGS), polymerase chain reaction (PCR)-based assays, immunohistochemistry (IHC), in situ hybridization (ISH), liquid biopsy, tissue biopsy, tumor biomarker
More news about: MarketsandMarkets
Aug 14, 2026, 10:15 ET IVD Raw Material Market worth $31.1 billion by 2031 - Exclusive Report by MarketsandMarkets™
Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, PCR, NGS), Disease (Hepatitis, HIV, HAI, TB, Flu, Syphilis), End User (Labs) - Global Forecast to 2030About MarketsandMarkets™ MarketsandMarkets™
More news about: MarketsandMarkets
Aug 12, 2026, 10:01 ET Cancer Tumor Profiling Market worth $19.87 billion by 2031 - Exclusive Report by MarketsandMarkets™
Cancer tumor profiling is shifting from tissue-dominant, single-marker, and centralized testing toward integrated precision-oncology workflows based on NGS comprehensive genomic profiling, liquid biopsy, longitudinal monitoring, AI-enabled interpretation, digital pathology, and multi-omics. The direct customers
More news about: MarketsandMarkets
Aug 11, 2026, 11:40 ET Unlocking High-Quality NGS Data from Challenging Clinical Samples, Upcoming Webinar Hosted by Xtalks
obstacle in biomarker-driven research and clinical trials. In this webinar, the featured speaker will discuss how nucleic acid yield and quality influence NGS success, review practical considerations when working with challenging clinical specimens and explain why FFPE remains one of the most important and
More news about: Xtalks
Aug 11, 2026, 06:37 ET n6 expands global distribution footprint, bringing iconPCR™ and AutoNorm to more scientists across Europe, the Middle East, and Africa
maker of the icon96™ and icon16 thermocyclers powered by iconPCR™ with AutoNorm intelligent normalization technology for next‑generation sequencing (NGS) library preparation, today announced new and expanded distribution partnerships that significantly increase access to its instruments across Europe,
More news about: n6
Aug 07, 2026, 10:15 ET Anatomic Pathology Market worth $14.5 billion by 2031 - Exclusive Report by MarketsandMarkets™
for genetic screening, parentage verification, and breed-specific health testing. Technological advancements, including next-generation sequencing (NGS), AI-enabled breeding, genomic evaluation, and reproductive technologies, are enabling faster genetic gain and more accurate selection decisions. This
More news about: MarketsandMarkets
Aug 06, 2026, 10:30 ET Multiomics Market worth $5.70 billion by 2031 - Exclusive Report by MarketsandMarkets™
sequencing & analysis/sample characterization segment dominated the market in 2025, driven by the widespread adoption of next-generation sequencing (NGS), high-resolution mass spectrometry, single-cell sequencing, and spatial omics technologies for comprehensive molecular profiling. Increasing demand
More news about: MarketsandMarkets
Aug 05, 2026, 04:00 ET Slone Partners Places Farhad Ghavami as Chief Executive Officer at SeqCenter
SeqCenter, a leading provider of next-generation sequencing (NGS) services supporting academic, biotechnology, pharmaceutical, government, and industrial customers worldwide.
More news about: Slone Partners
Jul 31, 2026, 10:30 ET Animal Genetics Market worth $9.37 billion by 2031 - Exclusive Report by MarketsandMarkets™
approaches primarily focused on selective breeding and basic molecular diagnostics. Newer technologies increasingly incorporate next-generation sequencing (NGS), genomic selection, bioinformatics, AI-driven breeding analytics, reproductive genomics, and gene-editing technologies such as CRISPR to accelerate
More news about: MarketsandMarkets